Status:

COMPLETED

Vytorin on Carotid Intima-media Thickness and Overall Rigidity

Lead Sponsor:

Hospital Universitario 12 de Octubre

Collaborating Sponsors:

Merck Sharp & Dohme LLC

Conditions:

Cardiovascular Diseases

Eligibility:

All Genders

30-75 years

Phase:

PHASE4

Brief Summary

Comparison of the effect on the progression of the carotid intima-media interphase thickness (GIM), arterial rigidity according to the measurement of the pulse wave speed and direct measurement of the...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Ldl-C Levels \>100 Mg/Dl
  • Patients Who Have Signed The Consent
  • Patients Of ages between 30 and 75 Years Old
  • Patients Of Both Genders
  • Patients With Established Cardiovascular Disease, Diabetes With Or Without Established Cardiovascular Disease
  • Patients Without Previous Treatment With Ezetimibe

Exclusion

    Key Trial Info

    Start Date :

    April 1 2005

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 1 2005

    Estimated Enrollment :

    90 Patients enrolled

    Trial Details

    Trial ID

    NCT00738296

    Start Date

    April 1 2005

    End Date

    December 1 2005

    Last Update

    June 24 2015

    Active Locations (0)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 0 (0 locations)

    No Results Found

    We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.